Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial. (2022)
Attributed to:
Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(21)00192-0
PubMed Identifier: 35028628
Publication URI: http://europepmc.org/abstract/MED/35028628
Type: Journal Article/Review
Volume: 3
Parent Publication: The Lancet. Microbe
Issue: 1
ISSN: 2666-5247